Discover
CUE
Cue Biopharma, Inc.
25.18
1 x 24.94
1 x 25.05
bid
ask
-
0.92
3.52%
01:32 PM
timesize
| Ytd | 175.19% | |
| 1y | 1.00% |
25.00
day range
26.91
4.98
52 week range
45.50
| Open | 26.10 | Prev Close | 26.10 | Low | 25.00 | High | 26.91 | Mkt Cap | 66.13M |
| Vol | 227.94K | Avg Vol | 131.88K | EPS | -0.94 | P/E | -26.77 | Forward P/E | -1.79 |
| Beta | 2.47 | Short Ratio | 1.54 | Inst. Own | 23.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 29.08 | 200-d Avg | 18.22 | 1yr Est | 3.60 |
| Income Statement | |||
| Total Revenue | 5.69M | ||
| Revenues (USD) | 5.69M | ||
| Gross Profit | 5.69M | ||
| Operating Expenses | 11.05M | ||
| Research and Development Expense | 6.90M | ||
| Selling, General and Administrative Expense | 4.15M | ||
| Operating Income | -5.36M | ||
| Interest Expense | 4.00K | ||
| Net Income | -5.18M | ||
| Net Income Common Stock | -5.18M | ||
| Net Income Common Stock (USD) | -5.18M | ||
| Consolidated Income | -5.18M | ||
| Earnings per Basic Share | -1.08 | ||
| Earnings per Basic Share (USD) | -1.08 | ||
| Earnings per Diluted Share | -1.08 | ||
| Earning Before Interest & Taxes (EBIT) | -5.17M | ||
| Earning Before Interest & Taxes (USD) | -5.17M | ||
| Weighted Average Shares | 4.81M | ||
| Weighted Average Shares Diluted | 4.81M | ||
| Balance Sheet | |||
| Cash and Equivalents | 17.17M | ||
| Cash and Equivalents (USD) | 17.17M | ||
| Trade and Non-Trade Receivables | 5.35M | ||
| Current Assets | 26.39M | ||
| Property, Plant & Equipment Net | 3.61M | ||
| Total Assets | 30.88M | ||
| Debt Current | 1.56M | ||
| Total Debt | 3.44M | ||
| Current Liabilities | 7.39M | ||
| Debt Non-Current | 1.88M | ||
| Total Liabilities | 9.27M | ||
| Accumulated Retained Earnings (Deficit) | -373.64M | ||
| Shareholders Equity | 21.61M | ||
| Shareholders Equity (USD) | 21.61M | ||
| Assets Non-Current | 4.49M | ||
| Total Debt (USD) | 3.44M | ||
| Liabilities Non-Current | 1.88M | ||
| Trade and Non-Trade Payables | 4.33M | ||
| Tax Assets | 1.90M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 929.00K | ||
| Net Cash Flow from Financing | 306.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.76M | ||
| Capital Expenditure | -121.00K | ||
| Issuance (Purchase) of Equity Shares | 306.00K | ||
| Net Cash Flow from Investing | -121.00K | ||
| Net Cash Flow from Operations | -10.94M | ||
| Share Based Compensation | 48.00K | ||